Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tehran University Of Medical Sciences

Clinical trials sponsored by Tehran University Of Medical Sciences, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Nasal spray painkiller: can a higher dose work better in the ER? Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 2 Not yet finished but already full! 2 Completed 3 Terminated 1

Experimental drug zavesca tested for rare fatal brain diseases in infants

Disease control Stopped early

This phase 3 trial tested the drug miglustat (Zavesca) in 30 infants with Sandhoff or Tay-Sachs diseases, rare genetic disorders that destroy nerve cells. The goal was to see if the drug could reduce hospitalizations, seizures, and feeding problems while improving motor function.…

Phase 3 • Sponsor: Tehran University of Medical Sciences • Aim: Disease control

Last updated Jun 26, 2026 17:51 UTC